Cutting-edge technology and multidisciplinary care offer hope for brain tumour patients, improving outcomes and quality of ...

Let’s hear the thoughts of some of the world’s leading glioma experts on the data from the study A Multilingual Overview of the INDIGO Study Data (Presented by Clinical Experts in French ...

A family have been left heartbroken by the death of an “amazing” mother whose headache at a football match turned out to be a ...

Biopsy specimen of a glioblastoma with prominent micovascular proliferation (formation of a mulitlayered "glomeruloid tuft", HE stain). (Jensflorian, CC BY-SA 3.0 , via Wikimedia Commons) From Philly ...

Introduction: Glioblastoma multiforme (GBM) ranks as one of the most aggressive primary malignant tumor affecting the brain. The persistent challenge of treatment failure and high relapse rates in GBM ...

Glioblastoma, the most common primary malignant brain tumor, currently has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. Despite evolving therapy ...

June 9, 2025 — A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating ...

Karol Nawrocki, a right-wing historian involved in Poland’s recent efforts to revise Holocaust history to minimize the role of local collaborators, has been elected president of Poland.

The Dutch governing coalition collapsed Tuesday after far-right politician Geert Wilders pulled out of the ruling bloc, accusing the other parties of not doing enough to curb immigration.

The data is the first-in-human result of its proprietary near-infrared (NIR) optical imaging agent, FG001, in patients with malignant glioma undergoing surgery. The article, published in the ...

Picture: Chris Stonham It got worse in the following weeks, which prompted a visit to A&E and the devastating diagnosis in May 2023 of a glioblastoma on her right temporal lobe. After multiple ...

A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging signs of efficacy in its first human trial. The vaccine – developed by researchers at the ...